![A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetes]()
A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetesE. J. Rhee; W. Y. Lee; K. H. Yoon; S. J. Yoo; I. K. Lee; S. H. Baik; Y. K. Kim; M. K. Lee; K. S. Park; J. Y. Park; B. S. Cha; H. W. Lee; K. W. Min; H. Y. Bae; M. J. Kim; J. A. Kim; D. K. Kim; S. W. Kim · 2010